The Effect of Moringa Oleifera Leaf Extract in Inhibition of NFkB Activation, TNF-a and ICAM-1 Expression in Oxydized LDL treated HUVECS
AbstractBackground. Atherosclerosis is a chronic inflammation process of vascu-lar endothelial cells. Increased oxydized LDL(OxLDL) is one of the most potent inducer of atherogenesis. OxLDL induces an increased ROS (Reac-tive Oxigen Species) and also acts as cytotoxic and chemotaxis factor for monocytes result in accumulation of inflammatory cells. Nuclear Factor Kappa Beta(NFkB) is a transcription factor that plays an important role in this inflammatory proces. NFkB compose of heterodimer molecules of p50 and p65, which bind to its inhibitor, IkB, leading to its inactive form in cytoplasm. OxLDL activates NFkB complex by phosphorylate IkB resulting in released p50-p65-IkB binding and translocation of p50-p65 into the nucleus. p50-p65 then binds to promoter and activates transcription of target genes. NFkB activation therefore increase gene and protein expressions of target molecules such TNF-a, ICAM-1, VICAM, etc. This study aimed to examine whether Moringa oleiferainhibits activation of NFkB dan expression of cytokine TNF-aand adhesion molecule ICAM-1.
Methods and results.Human umbilical vein endothelial cells (HUVECs) treated with OxLDL were used as model of atherosclerosis. The increased NFkB activity was measured by indirect method using p50 subcellular lo-calization by immunohistochemistry. 40ug/mL OxLDL, 0.01 gr/mL and 0.005 gr/mL Moringa oleiferawere used based on preliminary study.
Conclusions. This study showed that OxLDL significantly induce NFkB activation and increase protein expression of TNF-aand (ICAM-1). This study also observed that Moringa oleiferasignificantly inhibit NFkB activa-tion, and prevent an increased TNF-aand ICAM-1 expression at protein level in OxLDL-treated HUVECs as compare to the controls. Moringa oleifera dose of 0.01mg/mL has a better inhibition effect as compare to that of 0.005 gr/mL.
Caceres, A. Saravia, A. et.al, 1992. Pharmacologic Properties of Moringa Oleifera.2: Screening for Antispasmodik, antiinflamatory and Diuretic Activity, J Ethnopharmacol. 36:233-237
Faizi S. Siddiqui BS. Saleem R. 1995. Fully Acetylated Carbamate and Hypotensive Thiocarbonated Glycosidea from Moringa Oleifera. J. Phytochemistry. 38:957-963
Karr A, Choudhar y BK. Bandyopadhyay NG. 2003. Comparative Evaluation of Hypoglycaemic Activity of Some Indian Medicinal Plants in Allxan Diabetics Rats. J. Ethnopharmacol 84:105-108
Guevara AP. Vargas C, Sakurai H, et.al. 1999. An Antitumor Promoter from Moringa Oleifera Lam. Mutat Res. 440:181-188
Glasser SP, Selwyn MD, Ganz P. 1996. Atherosclerosis: Risk Factors and The Vascular Endothelium. Am Heart J. 131:379-384.
Collins, Tucker, Cybulsky, Myron I. 2001.NF-kB : Pivotal Mediator Or Innocent Bystander In Atherogenesis ?Journal of Clinical Investigation. 107: 255-263
Brand, K. 1996. Activated Transcription Factor Nuclear Factor Kappa Beta Is Present In Atherosclerotic Lesion.Journal of Clinical Investigation. 97: 1715-1722
Epstein, Franklin H. 1997. Nuclear Factor Kappa Beta- A Pivotal Transcription Factor in Chronic Inflammatory Disease. New Eng J Med. 15: 1066-1071.
Nakagawa, K; Kawagoe M. 2000. Differential Effects of Flavonoid Quercetin on Oxidative Damages Induced by Hydrophilic and Lipophilic Radical Generators in Hepatic Lysosomal Fractions of Mice. Journal of Health Science. 46: 509-512
Tak, P. Firestein, S. 2001. NF-ÊB : A Key Role In Inflammatory Diseases. The Journal of Clinical Investigation, Volume 107, No.1, p.7-10.
Ross, Russell. 1999. Atherosclerosis-An Inflammatory Disease. N. Eng J Med. 340: 115-126.
PDF (Bahasa Indonesia) downloads: 177
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).